Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Opt Lett ; 37(11): 2139-41, 2012 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-22660147

RESUMEN

In this Letter, we present an original method to extract the optical properties of surface plasmon polaritons (SPPs) on silver surfaces. A two Young's slit experiment combined with a leakage radiation microscope has been built. By correlating both imagery and coherence measurements on the same area, we are able to address the evolution of the SPP spatial coherence along its propagation. The proposed method could also be useful to explore the properties of complex plasmonic systems.

2.
Clin Exp Immunol ; 143(2): 329-37, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16412058

RESUMEN

Dendritic cells (DC) have been characterized recently as having an important role in the initiation and control of immunological response to Mycobacterium tuberculosis infection. Blood DC have been subdivided into myeloid (mDC) and plasmacytoid (pDC) subsets, on the basis of differences in phenotype markers and function. Little is known about the enumeration and functional evaluation of circulating DC in patients with tuberculosis and their correlation with clinical outcome during the course of anti-tuberculous treatment. We assessed circulating mDC and pDC counts measured by a newly developed single-platform flow cytometric assay based on TruCOUNT, as well as the production of interferon (IFN)-alpha after in vitro stimulation by herpes simplex virus (HSV-1) in 24 patients with active tuberculosis (TB) and 37 healthy donors. Absolute numbers of both DC subsets were decreased significantly in patients with active TB compared to controls. Similarly, the production of IFN-alpha was highly impaired. In 13 patients these parameters were assessed longitudinally, before and after the specific anti-microbial treatment. Most interestingly, in all nine patients with successful anti-tuberculous therapy there was a significant and marked increase of pDC counts and IFN-alpha production. In contrast, no significant longitudinal variations in DC counts and IFN-alpha production were observed in four patients with lack of response to specific treatment. In conclusion, active TB is associated with a defect in blood DC numbers and IFN-alpha production that is restored after bacterial clearance and clinical improvement, as a result of effective anti-tuberculous treatment.


Asunto(s)
Células Dendríticas/inmunología , Interferón-alfa/inmunología , Tuberculosis/inmunología , Adolescente , Adulto , Anciano , Antituberculosos/uso terapéutico , Recuento de Células/métodos , Femenino , Citometría de Flujo/métodos , Humanos , Leucocitos Mononucleares/inmunología , Masculino , Persona de Mediana Edad , Simplexvirus/inmunología , Resultado del Tratamiento , Tuberculosis/tratamiento farmacológico , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/inmunología
3.
Br J Psychiatry ; 175: 467-71, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10789280

RESUMEN

BACKGROUND: Axis I comorbidities are prevalent among patients with severe bipolar disorder but the clinical and psychopathological implications are not clear. AIMS: To investigate characteristics of four groups of patients categorised as follows: substance abuse only (group 1), substance abuse associated with other Axis I disorders (group 2), non-substance-abuse Axis I comorbidity (group 3), no psychiatric comorbidity (group 4). METHOD: Consecutive patients with bipolar disorder with psychotic features (n = 125) were assessed using the Structured Clinical Interview for DSM-III-R--patient version, and several psychopathological scales. RESULTS: By comparison with group 4, group 1 had a higher risk of having mood-incongruent delusions, group 2 had an earlier age at onset of mood disorder, a more frequent onset with a mixed state and a higher risk of suicide, and group 3 had more severe anxiety and a better awareness of illness. CONCLUSIONS: Substance abuse, non-substance-abuse Axis I comorbidity and their reciprocal association are associated with different characteristics of bipolar disorder.


Asunto(s)
Trastorno Bipolar/epidemiología , Trastornos Fóbicos/epidemiología , Trastornos Relacionados con Sustancias/epidemiología , Adulto , Edad de Inicio , Análisis de Varianza , Trastornos de Ansiedad/epidemiología , Estudios de Cohortes , Comorbilidad , Femenino , Humanos , Masculino , Trastorno de Pánico/epidemiología , Análisis de Regresión , Trastornos Somatomorfos/epidemiología
4.
Compr Psychiatry ; 39(2): 63-71, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9515190

RESUMEN

Seventy-two percent of 86 major depressive patients with atypical features as defined by the DSM-IV and evaluated systematically were found to meet our criteria for bipolar II and related "soft" bipolar disorders; nearly 60% had antecedent cyclothymic or hyperthymic temperaments. The family history for bipolar disorder validated these clinical findings. Even if we limit the diagnosis of bipolar II to the official DSM-IV threshold of 4 days of hypomania, 32.6% of atypical depressives in our sample would meet this conservative threshold, a rate that is three times higher than the estimates of bipolarity among atypical depressives in the literature. By definition, mood reactivity was present in all patients, while interpersonal sensitivity occurred in 94%. Lifetime comorbidity rates were as follows: social phobia 30%, body dysmorphic disorder 42%, obsessive-compulsive disorder 20%, and panic disorder (agoraphobia) 64%. Both cluster A (anxious personality) and cluster B (e.g., borderline and histrionic) personality disorders were highly prevalent. These data suggest that the "atypicality" of depression is favored by affective temperamental dysregulation and anxiety comorbidity, clinically manifesting in a mood disorder subtype that is preponderantly in the realm of bipolar II. In the present sample, only 28% were strictly unipolar and characterized by avoidant and social phobic features, without histrionic traits.


Asunto(s)
Trastorno Bipolar/diagnóstico , Trastorno Depresivo Mayor/diagnóstico , Adolescente , Adulto , Trastornos de Ansiedad/clasificación , Trastornos de Ansiedad/diagnóstico , Trastornos de Ansiedad/psicología , Trastorno Bipolar/clasificación , Trastorno Bipolar/psicología , Comorbilidad , Trastorno Ciclotímico/clasificación , Trastorno Ciclotímico/diagnóstico , Trastorno Ciclotímico/psicología , Trastorno Depresivo Mayor/clasificación , Trastorno Depresivo Mayor/psicología , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Trastornos de la Personalidad/clasificación , Trastornos de la Personalidad/diagnóstico , Trastornos de la Personalidad/psicología , Escalas de Valoración Psiquiátrica , Temperamento
7.
Clin Chim Acta ; 168(3): 281-6, 1987 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-3677426

RESUMEN

Plasma fibronectin (PF) concentrations, were investigated in normolipidaemic and hyperlipidaemic (type IV) patients with chronic renal failure treated with hemodialysis (n = 29) and in controls (n = 34). Mean PF was significantly reduced in both subsets of dialysed patients. Among the hemodialysed patients the presence of hyperlipidaemia did not modify PF levels, which resulted, on the contrary, significantly higher in hyperlipidaemic controls as compared with the normolipidaemic group. In controls, according to a multivariate analysis model, PF was directly related with age and inversely with HDL-cholesterol. In the hemodialysed patients total cholesterol was the unique significant PF related variate, being this group, therefore, characterized by the lack of any inverse relation between PF and HDL-cholesterol. Finally, no PF modifications were observed in hemodialyzed patients affected by arterial hypertension or clinically evident atherosclerotic lesions.


Asunto(s)
Fibronectinas/sangre , Hiperlipidemias/sangre , Fallo Renal Crónico/sangre , Diálisis Renal , Adulto , Anciano , Colesterol/sangre , Femenino , Humanos , Hiperlipidemias/complicaciones , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/terapia , Lipoproteínas/sangre , Masculino , Persona de Mediana Edad , Valores de Referencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA